Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
Total
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2018   0 58,270,934      
Beginning balance at Dec. 31, 2018 $ (15,422,443) $ 0 $ 58,271 $ 126,076,782 $ (141,557,496) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)     7,183,488      
Issuance of common stock 5,928,235   $ 7,184 5,921,051    
Stock options and warrants exercised (in shares)     510,894      
Stock options and warrants exercised 0   $ 511 (511)    
Deemed dividend (in shares)     116,496      
Deemed dividend 0   $ 116 86,091 (86,207)  
Stock-based compensation 876,918     876,918    
Effect of reclassification of warrants 857,072     857,072    
Value of warrants issued with preferred stock 6,709,961     6,709,961    
Net loss (26,324,372)       (26,324,372)  
Ending balance (in shares) at Jun. 30, 2019   0 66,081,812      
Ending balance at Jun. 30, 2019 (27,374,629) $ 0 $ 66,082 140,527,364 (167,968,075) 0
Beginning balance (in shares) at Mar. 31, 2019   0 61,496,990      
Beginning balance at Mar. 31, 2019 (17,995,810) $ 0 $ 61,497 129,764,361 (147,821,668) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)     3,957,432      
Issuance of common stock 2,928,500   $ 3,958 2,924,542    
Stock options and warrants exercised (in shares)     510,894      
Stock options and warrants exercised 0   $ 511 (511)    
Deemed dividend (in shares)     116,496      
Deemed dividend 0   $ 116 86,091 (86,207)  
Stock-based compensation 185,848     185,848    
Effect of reclassification of warrants 857,072     857,072    
Value of warrants issued with preferred stock 6,709,961     6,709,961    
Net loss (20,060,200)       (20,060,200)  
Ending balance (in shares) at Jun. 30, 2019   0 66,081,812      
Ending balance at Jun. 30, 2019 (27,374,629) $ 0 $ 66,082 140,527,364 (167,968,075) 0
Beginning balance (in shares) at Dec. 31, 2019   0 67,105,000      
Beginning balance at Dec. 31, 2019 (34,913,110) $ 0 $ 67,105 143,826,315 (178,806,530) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     12,911,234      
Stock options and warrants exercised, and vesting of restricted shares $ 47,158,399   $ 12,911 47,145,488    
Common stock issued for payment of series B preferred stock dividend (in shares) 617,284   617,284      
Common stock issued for preferred stock dividends $ 1,000,000   $ 618 999,382    
Conversion of convertible note (in shares)     8,384,270      
Conversion of Convertible Note 38,735,019   $ 8,384 38,726,635    
Common stock issued for interest payment on convertible note (in shares)     312,335      
Common stock issued for interest on Convertible Note 988,897   $ 312 988,585    
Stock-based compensation 2,029,218     2,029,218    
Net loss (126,575,218)          
Other comprehensive income 1,100,000         1,100,000
Ending balance (in shares) at Jun. 30, 2020   0 89,330,123      
Ending balance at Jun. 30, 2020 (70,476,795) $ 0 $ 89,330 233,715,623 (305,381,748) 1,100,000
Beginning balance (in shares) at Mar. 31, 2020   0 69,493,836      
Beginning balance at Mar. 31, 2020 (21,996,628) $ 0 $ 69,494 150,883,717 (174,049,839) 1,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     12,479,122      
Stock options and warrants exercised, and vesting of restricted shares $ 46,915,399   $ 12,479 46,902,920    
Common stock issued for payment of series B preferred stock dividend (in shares) 308,642   308,642      
Common stock issued for preferred stock dividends $ 500,000   $ 309 499,691    
Conversion of convertible note (in shares)     6,837,381      
Conversion of Convertible Note 33,541,467   $ 6,837 33,534,630    
Common stock issued for interest payment on convertible note (in shares)     211,142      
Common stock issued for interest on Convertible Note 724,685   $ 211 724,474    
Stock-based compensation 1,170,191     1,170,191    
Net loss (131,331,909)       (131,331,909)  
Other comprehensive income 0          
Ending balance (in shares) at Jun. 30, 2020   0 89,330,123      
Ending balance at Jun. 30, 2020 $ (70,476,795) $ 0 $ 89,330 $ 233,715,623 $ (305,381,748) $ 1,100,000